Subclinical Cushing's Disease with High-Molecular-Weight Forms of Adrenocorticotropic Hormone Production.

IF 0.9 Q4 ENDOCRINOLOGY & METABOLISM
Case Reports in Endocrinology Pub Date : 2024-03-25 eCollection Date: 2024-01-01 DOI:10.1155/2024/8721614
Takahiko Inukai, Nozomi Harai, Yukie Nakagawa, Tadatsugu Hosokawa, Airi Antoku, Yuko Muroi, Masakazu Ogiwara, Kyoichiro Tsuchiya
{"title":"Subclinical Cushing's Disease with High-Molecular-Weight Forms of Adrenocorticotropic Hormone Production.","authors":"Takahiko Inukai, Nozomi Harai, Yukie Nakagawa, Tadatsugu Hosokawa, Airi Antoku, Yuko Muroi, Masakazu Ogiwara, Kyoichiro Tsuchiya","doi":"10.1155/2024/8721614","DOIUrl":null,"url":null,"abstract":"<p><p>Production of the high-molecular-weight forms of adrenocorticotropic hormone (big-ACTH) has been reported in a small number of ectopic ACTH syndrome and ACTH-producing pituitary macroadenoma. However, perioperative changes in big-ACTH in patients with subclinical Cushing's disease have not been reported. A 63-year-old woman presented 25 × 20 × 20-mm-sized macroadenoma in the pituitary gland. Her early morning plasma ACTH and cortisol levels were 111 pg/mL and 11.6 <i>μ</i>g/dL, respectively. Cushingoid features and diurnal variation in plasma cortisol levels were not observed. The patient's urinary free cortisol (UFC) was 59.3 <i>μ</i>g/day. The corticotropin-releasing hormone (CRH) test showed that plasma ACTH levels were 1.5 times higher than the preload value. The overnight dexamethasone suppression test (DST) showed that the plasma cortisol level was not suppressed by 0.5 mg of dexamethasone (DEX) but was suppressed by 8 mg of DEX. Inferior pyramidal sinus sampling was consistent with Cushing's disease. Taken together, the patient was clinically diagnosed with subclinical Cushing's disease caused by an ACTH-producing pituitary adenoma. Endoscopic transsphenoidal adenomectomy was performed. In the postoperative CRH test, plasma ACTH levels showed six-fold increase. The postoperative DST showed cortisol suppression at 0.5 mg of DEX. The UFC levels decreased to 35.1 <i>μ</i>g/day. Pituitary contrast-enhanced MRI revealed no residual tumor, and plasma ACTH and cortisol levels remained within normal ranges. Gel filtration of preoperative and postoperative plasma ACTH was performed, and a high molecular weight fraction of ACTH was detected, which markedly decreased postoperatively. The absence of Cushingoid features and the lack of significant cortisol hypersecretion in this case were thought to be due in part to big-ACTH, which has low bioactivity. By careful evaluation of laboratory and clinical findings, we identified it as a big-ACTH-producing adenoma. This is the first report of a case in which the big-ACTH transition was observed perioperative and is a valuable case.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2024 ","pages":"8721614"},"PeriodicalIF":0.9000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985640/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/8721614","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Production of the high-molecular-weight forms of adrenocorticotropic hormone (big-ACTH) has been reported in a small number of ectopic ACTH syndrome and ACTH-producing pituitary macroadenoma. However, perioperative changes in big-ACTH in patients with subclinical Cushing's disease have not been reported. A 63-year-old woman presented 25 × 20 × 20-mm-sized macroadenoma in the pituitary gland. Her early morning plasma ACTH and cortisol levels were 111 pg/mL and 11.6 μg/dL, respectively. Cushingoid features and diurnal variation in plasma cortisol levels were not observed. The patient's urinary free cortisol (UFC) was 59.3 μg/day. The corticotropin-releasing hormone (CRH) test showed that plasma ACTH levels were 1.5 times higher than the preload value. The overnight dexamethasone suppression test (DST) showed that the plasma cortisol level was not suppressed by 0.5 mg of dexamethasone (DEX) but was suppressed by 8 mg of DEX. Inferior pyramidal sinus sampling was consistent with Cushing's disease. Taken together, the patient was clinically diagnosed with subclinical Cushing's disease caused by an ACTH-producing pituitary adenoma. Endoscopic transsphenoidal adenomectomy was performed. In the postoperative CRH test, plasma ACTH levels showed six-fold increase. The postoperative DST showed cortisol suppression at 0.5 mg of DEX. The UFC levels decreased to 35.1 μg/day. Pituitary contrast-enhanced MRI revealed no residual tumor, and plasma ACTH and cortisol levels remained within normal ranges. Gel filtration of preoperative and postoperative plasma ACTH was performed, and a high molecular weight fraction of ACTH was detected, which markedly decreased postoperatively. The absence of Cushingoid features and the lack of significant cortisol hypersecretion in this case were thought to be due in part to big-ACTH, which has low bioactivity. By careful evaluation of laboratory and clinical findings, we identified it as a big-ACTH-producing adenoma. This is the first report of a case in which the big-ACTH transition was observed perioperative and is a valuable case.

高分子量肾上腺皮质激素分泌型亚临床库欣病
少数异位促肾上腺皮质激素(ACTH)综合征和促肾上腺皮质激素垂体大腺瘤患者体内会产生高分子量的促肾上腺皮质激素(big-ACTH)。然而,亚临床库欣病患者围手术期大-促肾上腺皮质激素(big-ACTH)的变化尚未见报道。一名 63 岁的妇女出现了 25 × 20 × 20 毫米大小的垂体大腺瘤。她清晨的血浆促肾上腺皮质激素和皮质醇水平分别为 111 pg/mL 和 11.6 μg/dL。没有观察到库欣样特征和血浆皮质醇水平的昼夜变化。患者的尿游离皮质醇(UFC)为 59.3 μg/天。促肾上腺皮质激素释放激素(CRH)检测显示,血浆促肾上腺皮质激素水平是负荷前值的 1.5 倍。过夜地塞米松抑制试验(DST)显示,0.5 毫克地塞米松(DEX)不能抑制血浆皮质醇水平,但 8 毫克地塞米松(DEX)可抑制血浆皮质醇水平。下锥体窦取样与库欣病一致。综上所述,患者被临床诊断为由分泌促肾上腺皮质激素的垂体腺瘤引起的亚临床库欣病。患者接受了内窥镜经蝶窦腺瘤切除术。术后CRH检测显示,血浆促肾上腺皮质激素(ACTH)水平升高了6倍。术后DST显示皮质醇在0.5毫克DEX时受到抑制。UFC 水平降至 35.1 μg/天。垂体造影剂增强 MRI 显示没有残留肿瘤,血浆促肾上腺皮质激素和皮质醇水平仍在正常范围内。对术前和术后血浆促肾上腺皮质激素进行了凝胶过滤,检测到高分子量部分的促肾上腺皮质激素,术后明显减少。该病例没有库欣样特征,也没有明显的皮质醇分泌过多现象,这在一定程度上是由于生物活性较低的大促肾上腺皮质激素所致。通过对实验室和临床结果的仔细评估,我们确定该病例为大-ACTH 腺瘤。这是首例在围手术期观察到 big-ACTH 转变的病例报告,是一个有价值的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Endocrinology
Case Reports in Endocrinology ENDOCRINOLOGY & METABOLISM-
CiteScore
2.10
自引率
0.00%
发文量
45
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信